- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 239/94 - Atomes d'azote
Détention brevets de la classe C07D 239/94
Brevets de cette classe: 702
Historique des publications depuis 10 ans
|
44
|
34
|
40
|
42
|
27
|
55
|
47
|
37
|
25
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Araxes Pharma LLC | 92 |
18 |
| The Regents of the University of California | 20296 |
16 |
| Boehringer Ingelheim International GmbH | 4615 |
12 |
| NATCO Pharma Limited | 205 |
12 |
| Gilead Sciences, Inc. | 2108 |
10 |
| Bristol-myers Squibb Company | 4797 |
8 |
| Genentech, Inc. | 4005 |
8 |
| Janssen Pharmaceutica N.V. | 3344 |
7 |
| CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 201 |
7 |
| Dana-Farber Cancer Institute, Inc. | 2619 |
7 |
| Merck Patent GmbH | 5733 |
6 |
| The Trustees of Columbia University in the City of New York | 3597 |
6 |
| Northwestern University | 3458 |
6 |
| Asana Biosciences, LLC | 43 |
6 |
| Chiesi Farmaceutici S.p.A. | 964 |
6 |
| Council of Scientific & Industrial Research | 1430 |
6 |
| Evotec International GmbH | 89 |
6 |
| Institute of Organic Chemistry and Biochemistry of the AS CR, v.v.i. | 13 |
6 |
| The Scripps Research Institute | 1354 |
6 |
| Shanghai Allist Pharmaceuticals, Inc. | 24 |
6 |
| Autres propriétaires | 537 |